Small intestinal bacterial overgrowth: diagnosis and treatment

Antonio Gasbarrini, Veronica Ojetti, Giovanni Battista Gasbarrini, Maurizio Gabrielli, Emidio Scarpellini, Andrea Lupascu, Ec Lauritano

Research output: Contribution to journalArticle

101 Citations (Scopus)


Small intestinal bacterial overgrowth (SIBO) is a clinical condition characterized by a malabsorption syndrome due to an increase in microorganisms within the small intestine. The main mechanisms restricting bacterial colonization in the upper gut are the gastric acid barrier, mucosal and systemic immunity and intestinal clearance. When these mechanisms fail, bacterial overgrowth develops. Diarrhea, steatorrhea, chronic abdominal pain, bloating and flatulence are common symptoms and are similar to those observed in irritable bowel syndrome. Breath tests (glucose and/or lactulose breath tests) have been proposed as a sensitive and simple tool for the diagnosis of bacterial overgrowth, being non-invasive and inexpensive compared to the gold standard represented by the culture of intestinal aspirates. Antibiotic therapy is the cornerstone of SIBO treatment. Current SIBO treatment is based on empirical courses of broad-spectrum antibiotics since few controlled studies concerning the choice and duration of antibiotic therapy are available at present.
Original languageEnglish
Pages (from-to)237-240
Number of pages4
JournalDigestive Diseases
Publication statusPublished - 2007


  • Anti-Bacterial Agents
  • Bacterial Infections
  • Humans
  • Intestine, Small

Fingerprint Dive into the research topics of 'Small intestinal bacterial overgrowth: diagnosis and treatment'. Together they form a unique fingerprint.

Cite this